Garuda Therapeutics
@garudatx
Creating off-the-shelf, long-term durable blood stem cell therapies
ID: 1440714337895653377
22-09-2021 16:28:02
17 Tweet
49 Followers
1 Following
We’re excited to announce the launch of Garuda Therapeutics with $72 million in Series A financing. Co-founded by Dhvanit Shah, Kiran Reddy, David Scadden, and Sean Morrison, Garuda is committed to changing the world of blood stem cell transplants. More @ businesswire.com/news/home/2021…
We are pleased to announce that biopharma veteran & current @DecibelTx CEO, Laurence Reid, Ph.D., has joined Garuda’s Board of Directors. bwnews.pr/3sXGM3h
Recently the Garuda team gathered for golf, games and good food to celebrate the end of summer! Thanks to Kimball Farm for having us!
We are pleased to announce that Garuda’s CEO Dhvanit Shah will be presenting at the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14, 2022.